ripekg:evaluation/RIPEA72DC7586F4A2C751 |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:evidence-aggregation/RIPEA72DC7586F4A2C751 |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:integrity-assessment-hypothesis/RIPEA72DC7586F4A2C751-human-1-1 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:integrity-assessment-hypothesis/RIPEA72DC7586F4A2C751-human-1-2 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:integrity-assessment-hypothesis/RIPEA72DC7586F4A2C751-human-1-3 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:integrity-assessment-hypothesis/RIPEA72DC7586F4A2C751-human-2-2 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:integrity-assessment-hypothesis/RIPEA72DC7586F4A2C751-human-overall |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:integrity-assessment-hypothesis/RIPEA72DC7586F4A2C751-inspectai-1-1 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:integrity-assessment-hypothesis/RIPEA72DC7586F4A2C751-inspectai-1-2 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:integrity-assessment-hypothesis/RIPEA72DC7586F4A2C751-inspectai-1-3 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:integrity-assessment-hypothesis/RIPEA72DC7586F4A2C751-inspectai-2-2 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:peer-comment/RIPEA72DC7586F4A2C751-1 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:publication-details/RIPEA72DC7586F4A2C751The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:registry-evidence/RIPEA72DC7586F4A2C751 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
rdf:type |
rdfs:Resource |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
rdf:type |
owl:Thing |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
rdf:type |
ripe:ResearchIntegrityAssessmentResearch integrity assessment |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
rdf:type |
tido:Case |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripe:assesses |
ripekg:work/10.1055%2Fs-0043-107242The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripe:assesses |
ripekg:work/10.1055%2Fs-0043-107242The effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
tido:investigates |
ripekg:integrity-assessment-question/post-publication-notices/1.0.01.2. Does the study have an associated expression of concern or other relevant post-publication notice? |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
tido:investigates |
ripekg:integrity-assessment-question/post-publication-notices/1.0.0post-publication notices |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
tido:investigates |
ripekg:integrity-assessment-question/research-team-related-concerns/1.0.01.3. Do other studies by the research team highlight causes for concern? |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
tido:investigates |
ripekg:integrity-assessment-question/research-team-related-concerns/1.0.0research-team-related concerns |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
tido:investigates |
ripekg:integrity-assessment-question/retraction-status/1.0.01.1. Does the study have an associated retraction? |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
tido:investigates |
ripekg:integrity-assessment-question/retraction-status/1.0.0retraction status |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
tido:investigates |
ripekg:integrity-assessment-question/study-registration/1.0.02.2. Are there concerns relating to the timing or absence of study registration? |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
tido:investigates |
ripekg:integrity-assessment-question/study-registration/1.0.0study registration |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
tido:investigates |
ripekg:overall-integrity-assessment-question/1.0.0What is the overall integrity assessment of the study? |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
tido:investigates |
ripekg:overall-integrity-assessment-question/1.0.0overall integrity assessment |
ripekg:retraction-notice/28312Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: a double-blind randomized controlled clinical trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/28452Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/28467The effects of magnesium and vitamin E co-supplementation on parameters of glucose homeostasis and lipid profiles in patients with gestational diabetes |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/40898Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/54767Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67044Effect of daily consumption of probiotic yoghurt on lipid profiles in pregnant women: a randomized controlled clinical trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67046Effect of multivitamin versus multivitamin-mineral supplementation on metabolic profiles and biomarkers of oxidative stress in pregnant women: a double-blind randomized clinical trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67047The favorable effects of garlic intake on metabolic profiles, hs-CRP, biomarkers of oxidative stress and pregnancy outcomes in pregnant women at risk for pre-eclampsia: randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67050Omega-3 fatty acid supplementation affects pregnancy outcomes in gestational diabetes: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67052The effect of zinc and vitamin E cosupplementation on metabolic status and its related gene expression in patients with gestational diabetes |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67053The effect of zinc and vitamin E cosupplementation on metabolic status and its related gene expression in patients with gestational diabetes |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67323Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67324Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67383The effects of vitamin D and probiotic co-supplementation on glucose homeostasis, inflammation, oxidative stress and pregnancy outcomes in gestational diabetes: A randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67384Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67433Clinical and metabolic response to probiotic administration in people with Parkinson's disease: A randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67435Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67436Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67437The effects of probiotic and selenium co-supplementation on mental health parameters and metabolic profiles in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67438Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67440The effects of vitamin E supplementation on endometrial thickness, and gene expression of vascular endothelial growth factor and inflammatory cytokines among women with implantation failure |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67441The Effects of Probiotic Supplementation on Gene Expression Related to Inflammation, Insulin, and Lipids in Patients With Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67442The Effects of Coenzyme Q10 Supplementation on Glucose Metabolism, Lipid Profiles, Inflammation, and Oxidative Stress in Patients With Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67443The effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:retraction-notice/67444Magnesium-zinc-calcium-vitamin D co-supplementation improves glycemic control and markers of cardiometabolic risk in gestational diabetes: a randomized, double-blind, placebo-controlled trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |
ripekg:study-design-evidence/RIPEA72DC7586F4A2C751 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA72DC7586F4A2C751 |